In addition, another meta-analysis with a comparable update, focusing on postmenopausal breast cancer only and considering prospective studies only, provided a similar summary point estimate (RR = 0.94), which, however, was only marginally significant (95% CI, 0.88–1.01) [ 24 ].
1
—
—